Asia Pacific Infusion Devices Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis.

The Asia Pacific infusion devices market size is expected to reach US$ 5,490.48 million by 2031 from US$ 3,014.20 million in 2023. The market is estimated to record a CAGR of 7.8% from 2023 to 2031.

Executive Summary and Asia Pacific Infusion Devices Market Analysis:

The market in Asia Pacific is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The region accounted for the highest growth rate owing to the increasing concentration of market players developing novel products at affordable prices, initiatives by the local government authorities, and a rise in the prevalence of cancer and diabetes. In addition, the presence of local market players in Asia Pacific enhances the availability of infusion devices in the region.

Asia Pacific Infusion Devices Market Strategic Insights

Get more information on this report Request Free Sample PDF

Asia Pacific Infusion Devices Market Segmentation Analysis

Key segments that contributed to the derivation of the Asia Pacific infusion devices market analysis are product type, infusion pumps, infusion sets, application and end user.

• By product type, the Asia Pacific infusion devices market is bifurcated into infusion pumps and infusion sets. The infusion pumps held a larger share of the market in 2023.
• In terms of infusion pumps, the market is segmented into volumetric pumps, syringe pumps, insulin pumps, patient control analgesia (PCA) pumps, enteral pumps, implantable pumps, and elastomeric pumps. The volumetric pumps segment held the largest share of the market in 2023.
• By infusion sets, the Asia Pacific infusion devices market is bifurcated into vented infusion sets and non-vented infusion sets. The vented infusion sets held a larger share of the market in 2023.
• By application, the Asia Pacific infusion devices market is segmented into diabetes, oncology, pain management, hematology, pediatrics, gastroenterology, and other. The diabetes held the largest share of the market in 2023.
• By end user, the Asia Pacific infusion devices market is segmented into hospitals and specialty clinics, homecare settings, ambulatory surgical centers, and others. The hospitals and specialty clinics held the largest share of the market in 2023.

Asia Pacific Infusion Devices Market Outlook

Various market players focus on strategic developments such as product launches, mergers, acquisitions, and collaborations to develop advanced products that ease the treatment of chronic disorders such as diabetes, cancer, and chronic pain. The following are a few recent developments in the Asia Pacific infusion devices market. In February 2023, Mindray launched its BeneFusion i Series and u Series infusion systems, featuring high precision, adaptive customization and extraordinary simplicity for guaranteed levels of medication safety in a variety of clinical settings.  In March 2022, Fresenius Kabi received 510(k) regulatory clearance from the FDA for its wireless Agilia Connect Infusion System. The system includes Agilia Volumetric Pump and Agilia Syringe Pump with Vigilant Software Suite-Vigilant Master Med technology. Both pumps are the first to be cleared following TIR101 standards, which were developed by the Association for the Advancement of Medical Instrumentation (AAMI) in 2021. In January 2021, Eitan Medical, a global leader in advanced infusion therapy, launched a UK operation to improve its support of Sapphire infusion pump customers, which include NHS Trusts, private hospitals, and home care providers. An upsurge in the number of product approvals, launches, and strategic collaborations is likely to create lucrative opportunities for the infusion devices market in the future.

Asia Pacific Infusion Devices Market Country Insights

Based on country, the Asia Pacific infusion devices market comprises China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China held the largest share in 2023.

In October 2021, EOFlow Co., Ltd., a provider of wearable drug delivery solutions, announced the establishment of a joint venture company called "SINOFLOW Co., Ltd." in China with Changsha Sinocare Co., Ltd. to enter the large and growing Chinese diabetes market. The joint venture company EOFlow and Sinocare manufacture and distribute EOFlow's wearable, disposable insulin pump "EOPatch" and its future products in the Greater China Region. According to World Integrated Trade Solution, China imported over 2 million Infusion pumps worth US$ 0. 235 million in 2023, gaining a second position in the list of top importers of infusion pumps. Such developments in the infusion devices market in China, coupled with the mounting prevalence of chronic diseases requiring infusion therapies, are boosting the growth of the market.

Asia Pacific Infusion Devices Market Report Highlights

Asia Pacific Infusion Devices Market Company Profiles

Some of the key players operating in the market include B Braun SE, Baxter International Inc, Becton Dickinson and Co, BPL Medical Technologies Pvt Ltd, CODAN US Corp, Eitan Medical Ltd, Elimedical Inc, Fresenius Kabi AG, ICU Medical Inc, KD Scientific Inc, Medtronic Plc, Moog Inc, Nipro Corp, Polymedicure, Tandem Diabetes Care Inc, Terumo Corp, and Zimed Healthcare Ltd, among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Asia Pacific Infusion Devices Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations.
• Industry trade journals and other relevant publications.
• Government documents, statistical databases, and market reports.
• News articles, press releases, and webcasts specific to companies operating in the market.

Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

• Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research.
• Enhance the expertise and market understanding of the analysis team.
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Asia Pacific Infusion Devices Market Country and Regional Insights